Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $45.00 at Evercore ISI
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also recently weighed in on the stock. Canaccord Genuity Group lifted their price objective […]
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also recently weighed in on the stock. Canaccord Genuity Group lifted their price objective […]
